Galacto-oligosaccharides (GOS) represent non-digestible glycans that are commercially produced by transgalactosylation of lactose, and that are widely used as functional food ingredients in prebiotic formulations, in particular in infant nutrition. GOS consumption has been reported to enhance growth of specific bacteria in the gut, in particular bifidobacteria, thereby supporting a balanced gut microbiota. In a previous study, we assessed the hydrolytic activity and substrate specificity of seventeen predicted β-galactosidases encoded by various species and strains of infant-associated bifidobacteria. In the current study, we further characterized seven out of these seventeen bifidobacterial β-galactosidases in terms of their kinetics, enzyme stability and oligomeric state. Accordingly, we established whether these β-galactosidases are capable of synthesizing GOS via enzymatic transgalactosylation employing lactose as the feed substrate. Our findings show that the seven selected enzymes all possess such transgalactosylation activity, though they appear to differ in their efficiency by which they perform this reaction. From chromatography analysis, it seems that these enzymes generate two distinct GOS mixtures: GOS with a relatively short or long degree of polymerization profile. These findings may be the stepping stone for further studies aimed at synthesizing new GOS variants with novel and/or enhanced prebiotic activities and potential for industrial applications.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126724PMC
http://dx.doi.org/10.3389/fmicb.2021.662959DOI Listing

Publication Analysis

Top Keywords

bifidobacterial β-galactosidases
8
synthesizing gos
8
gos
6
infant-associated bifidobacterial
4
β-galactosidases
4
β-galactosidases ability
4
ability synthesize
4
synthesize galacto-oligosaccharides
4
galacto-oligosaccharides galacto-oligosaccharides
4
galacto-oligosaccharides gos
4

Similar Publications

Nanomedical applications have increased significantly. This work aimed to fabricate and characterize cobalt oxide nanoparticles (CoOnps) synthesized biologically via aqueous Alhagi maurorum extract and evaluate their cytotoxic and antimicrobial impacts. Green-synthesized CoOnps were prepared and analyzed using UV-Vis spectrophotometer UV-vis, Scanning electron microscopy (SEM), Transmission electron microscopy TEM, Energy dispersive X-ray analysis EDAX, Fourier transform infrared, FTIR, and X-ray diffraction (XRD).

View Article and Find Full Text PDF

Bifidobacteria antagonize the life cycle of Clostridioides difficile.

Microb Pathog

February 2025

Centro de Investigación y Desarrollo en Ciencia y Tecnología de los Alimentos (CCT- La Plata CONICET, CIC-PBA, Facultad de Ciencias Exactas, UNLP), Argentina; Cátedra de Microbiología. Departamento de Ciencias Biológicas, Facultad de Ciencias Exactas, UNLP), Argentina; Consejo Nacional de Investigaciones Científicas y Tecnológicas (CONICET), Buenos Aires, Argentina. Electronic address:

Clostridioides difficile is a spore-forming pathogen capable of causing severe disease in humans. Critical stages in the biological cycle of this microorganism include sporogenesis/germination and toxin production by vegetative cells. Antagonizing these pivotal events could aid in prevention and treatment to manage this pathogen.

View Article and Find Full Text PDF
Article Synopsis
  • Gum arabic is important in the food industry for its ability to stabilize and emulsify, and it also supports the growth of beneficial gut bacteria like Bifidobacterium.
  • The two types of gum arabic, Acacia senegal and A. seyal, both have a protein component called arabinogalactan protein (AGP), but they differ in their structure.
  • This research identifies a new enzyme that breaks down specific components of A. seyal gum, revealing its structure and showing how Bifidobacterium catenulatum can use these sugars for growth.
View Article and Find Full Text PDF

Background: Colorectal cancer (CRC), with a growing incidence trend, is one of the most diagnosed cancers and the second cause of cancer-related deaths worldwide. The literature has frequently focused attention on the correlation between the gut microbiota imbalance and CRC. The genera Lactobacillus and Bifidobacterium have recently received increasing attention because of their potential in restoring alterations in the gut microflora.

View Article and Find Full Text PDF
Article Synopsis
  • The early life stages are very important for how the gut microbiome develops, affecting health later on.
  • Factors like using antibiotics, being born through C-section, and formula feeding can harm this development.
  • A new model called I-TIM-2 helps scientists study how different diets and ingredients, like human milk oligosaccharides, can change the gut bacteria in infants.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!